Delivery Order SPE2DE23D0008-SPE2D625F2JAR
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $3,021 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SCF 415CC breast implants. The contract, which carries no set-aside designation, reflects Allergan's status as a sole-source provider of specialized reconstructive and aesthetic surgical devices to the federal government. The award is structured as a fixed-price contract with economic price adjustment, with performance...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,425.00 for Natrelle Inspira SCM 560CC breast implants by the Defense Logistics Agency Medical Supply Chain, a Defense agency division. The award, issued on August 14, 2025, represents a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of August 18, 2025. The contract was awarded without set-aside designation, reflecting Allergan's status as a...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $1,200 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SSF 325CC breast implants. This delivery order, awarded on July 24, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements. The contract does not utilize a set-aside designation, reflecting Allergan's position...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $3,021 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to supply breast implants. The order is being issued against Allergan's existing $13.5 million Indefinite Delivery Indefinite Quantity contract with the agency, which facilitates the procurement of Allergan's specialty medical devices and implants for use in reconstructive surgeries at Military Treatment Facilities. As the sole-source provider...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,075 delivery order by the Defense Logistics Agency Medical Supply Chain on September 11, 2025, for Natrelle Inspira SSF 485CC breast implants with a completion date of September 15, 2025. This fixed-price contract with economic price adjustment will be performed in Irvine, California and does not utilize a set-aside designation. The award represents a child order under one of Allergan's larger indefinite delivery vehicles,...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $2,814 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to supply Natrelle Inspira SSM 405cc breast implants. Performance will occur at Allergan's facility in Irvine, California, with no set-aside designation applied. As a sole-source provider of proprietary breast implant products, Allergan will deliver the devices to support reconstructive surgeries at military treatment facilities. This award is...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order on September 11, 2025, for Natrelle Inspira SCX 495CC breast implants, with a completion date of September 15, 2025. The contract was awarded without a set-aside designation and is being performed in Irvine, California. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain division, which oversees procurement of specialized medical devices for the Department of...
- The U.S. Department of Defense Medical Supply Chain, operating through the Defense Logistics Agency Troop Support Medical, awarded a $2,814 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCX 800cc breast implants. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 25, 2025, represents a child order under one of Allergan's existing Indefinite Delivery Vehicles—specifically a $13.5 million IDV for...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F2JARDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $4,014 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain division for Natrelle Inspira SCF 605CC breast implants. The contract is a fixed-price delivery order with economic price adjustment clause, with a completion date of September 4, 2025. The place of performance is located in Irvine, California. This award was made without a set-aside designation, reflecting Allergan's position as a specialized sole-source provider of these surgical devices to federal healthcare systems. This delivery order is issued under one of two significant Indefinite Delivery Vehicles that Allergan holds with DLA Troop Support Medical, established on December 8, 2022, with a total value of $13.5 million. The contract structure includes a one-year base period followed by four one-year option periods. These IDVs enable the provision of Natrelle breast implants and related surgical devices to Department of Defense research centers, hospitals, and clinics, supporting reconstructive and aesthetic surgical procedures for military members, veterans, and other eligible populations. Allergan's federal contracting history demonstrates consistent delivery of specialized medical technologies to military treatment facilities and Veterans Affairs hospitals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/2/25 |